Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A double-blind, placebo controlled, multicenter, multinational, phase III study to evaluate the safety and efficacy of Sarizotan HCl 1 mg b.i.d in patients with Parkinson' s disease suffering from treatment-associated dyskinesia https://kusajili.com:443/Trial/vIj8yvL1hkePkqi_ffFc6Q%24a-double-blind-placebo-controlled-multicenter-multinational-phase-iii-study-to-evaluate-the-safety-and-efficacy-of-sarizotan-hc
I have read and accept the terms of use of the site and the Privacy Policy
Send your message